These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20373380)

  • 21. [Regulation of body iron homeostasis by hepcidin].
    Lipiński P; Starzyński RR
    Postepy Hig Med Dosw (Online); 2004 Mar; 58():65-73. PubMed ID: 15069380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary hemochromatosis--a new look at an old disease.
    Pietrangelo A
    N Engl J Med; 2004 Jun; 350(23):2383-97. PubMed ID: 15175440
    [No Abstract]   [Full Text] [Related]  

  • 23. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations.
    Flanagan JM; Peng H; Beutler E
    Alcohol Clin Exp Res; 2007 Jan; 31(1):138-43. PubMed ID: 17207112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
    Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ
    Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepcidin comes to the rescue.
    Luft FC
    J Mol Med (Berl); 2004 Jun; 82(6):345-7. PubMed ID: 15148581
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel observations in hereditary hemochromatosis: potential implications for clinical strategies.
    Swinkels DW; Fleming RE
    Haematologica; 2011 Apr; 96(4):485-8. PubMed ID: 21454877
    [No Abstract]   [Full Text] [Related]  

  • 28. Review article: the genetic basis of haemochromatosis.
    Griffiths WJ
    Aliment Pharmacol Ther; 2007 Aug; 26(3):331-42. PubMed ID: 17635368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron genes, dysmetabolism and fibrosis in chronic hepatitis C.
    Valenti L; Dongiovanni P; Fargion S; Fracanzani AL
    J Hepatol; 2008 Mar; 48(3):513-4; author reply 514-5. PubMed ID: 18194822
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hereditary haemochromatosis: novel genes, novel diseases and hepcidin].
    Bergmans JP; Kemna EH; Janssen MC; Jacobs EM; Stalenhoef AF; Marx JJ; Swinkels DW
    Ned Tijdschr Geneeskd; 2007 May; 151(20):1121-7. PubMed ID: 17557668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypersiderosis and dissiderosis in the context of data on hemochromatosis microelementosis].
    Smirnov OA
    Arkh Patol; 2008; 70(3):3-8. PubMed ID: 18727423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis.
    Island ML; Jouanolle AM; Mosser A; Deugnier Y; David V; Brissot P; Loréal O
    Haematologica; 2009 May; 94(5):720-4. PubMed ID: 19286879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemochromatosis and pregnancy: iron stores in the Hfe-/- mouse are not reduced by multiple pregnancies.
    Neves JV; Olsson IA; Porto G; Rodrigues PN
    Am J Physiol Gastrointest Liver Physiol; 2010 Apr; 298(4):G525-9. PubMed ID: 20110460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history and management of HFE-hemochromatosis.
    Gan EK; Powell LW; Olynyk JK
    Semin Liver Dis; 2011 Aug; 31(3):293-301. PubMed ID: 21901659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical expression of hemochromatosis gene (HFE) variants.
    Ayonrinde OT; Olynyk JK
    Hepatology; 2007 Oct; 46(4):960-2. PubMed ID: 17894321
    [No Abstract]   [Full Text] [Related]  

  • 37. [Primary hemochromatosis as a disease provoked by hepcidin deficiency?].
    Iwai K; Hishikawa K
    Nihon Rinsho; 2006 Sep; Suppl 3():611-5. PubMed ID: 17022620
    [No Abstract]   [Full Text] [Related]  

  • 38. Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis.
    Arnold J; Sangwaiya A; Bhatkal B; Arnold A
    Med Hypotheses; 2008; 70(6):1197-200. PubMed ID: 18054440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HFE-related hemochromatosis risk mutations in Latvian population.
    Peculis R; Lace B; Putnina A; Nikitina-Zake L; Klovins J
    Ann Hematol; 2015 Feb; 94(2):343-4. PubMed ID: 25015053
    [No Abstract]   [Full Text] [Related]  

  • 40. HFE gene and hemochromatosis.
    Anderson GJ; Ramm GA; Subramaniam VN; Powell LW
    J Gastroenterol Hepatol; 2004 Jun; 19(6):712. PubMed ID: 15151632
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.